Evaluation of androgenic status in patients with primary hypothyroidism

Main Article Content

T.I. Krytskyi


Background. Role of androgenic deficiency in men as a factor of disease pathogenesis is beyond doubt. Interaction of thyroid and sexual hormones in men with hypothyroidism remains controversial. The purpose was to evaluate androgenic status in men with primary hypothyroidism depending on its duration and state of compensation. Materials and methods. We have examined 45 male patients with primary hypothyroidism aged 35 to 60 years. Enrollment of men was conducted during outpatient visits and in-patient treatment in the endocrinology department of the Ternopil University hospital. Results. Decreased level of total testosterone (tТ) was detected in 42.2 % of patients with hypothyroidism. Thus, in 17.8 % of patients, tТ blood level was below 8.0 nM/l, and in 11 (24.4 %) men, this index was between 8.0 and 12.0 nM/l. According to the results of evaluating the content of free testosterone, the incidence of laboratory hypogonadism in men with hypothyroidism appeared to be higher than when determining tТ. The degree of hypothyroidism compensation did not influence significantly the average levels of gonadotropic and sexual hormones. Conclusions. Levels of sex hormone-binding globulin were significantly decreased in 46.7 % of patients with hypothyroidism as compared to the control group. The average levels of estradiol in the examined patients did not differ significantly from the average indexes in men from the control group. The obtained data may indicate a combined lesion of the central and peripheral links of the pituitary-gonadal system in men with hypothyroidism.

Article Details

How to Cite
Krytskyi, T. “Evaluation of Androgenic Status in Patients With Primary Hypothyroidism”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 3, Apr. 2018, pp. 278-84, doi:10.22141/2224-0721.14.3.2018.136427.
Clinical Thyroidology


Kravchenko VI, Postol SV. Incidence of thyroid pathology in Ukraine. Mìžnarodnij endokrinologìčnij žurnal. 2011;(35):26-31. (in Ukrainian).

Visser WE, Visser TJ, Friesema EC, Visser TJ. Thyroid hormone transport in and out of cells. Trends Endocrinol Metab. 2008 Mar;19(2):50-6. doi: 10.1016/j.tem.2007.11.003.

Carani C, Isodori A, Granata A. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005 Dec;90(12):6472-9. doi: 10.1210/jc.2005-1135.

Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring international of late-onset hypogonadism in males: ISA, ISSAM, EAU recommendations. Int J Androl. 2005 Jun;28(3):125-127. doi: 10.1111/j.1365-2605.2005.00553.x.

Crawford М, Kennedy L. Testosterone replacement therapy: role of pituitary and thyroid in diagnosis and treatment. Transl Androl Urol. 2016;5(6):850-858. doi: 10.21037/tau.2016.09.01.

Luchytskyy YeV, Luchytskyy VYе, Tronko MD. Male hypogonadism. Mìžnarodnij endokrinologìčnij žurnal. 2017;13(4):281-289. doi: 10.22141/2224-0721.13.4.2017.106658. (in Ukrainian).

Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur Urol. 2009 Jan;55(1):121-30. doi: 10.1016/j.eururo.2008.08.033.

Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: сorrelations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007;30(4):911-917. doi: 10.2337/dc06-1426.

Schooling CM. Androgen activity and markers of inflammation among men in NHANES III. Am J Hum Biol. 2013 Sep-Oct;25(5):622-8. doi: 10.1002/ajhb.22421.

Duan CW, Xu L. Testosterone and androstanediol glucuronide among men in NHANES III. BMC Public Health. 2018;18(1):339. doi: 10.1186/s12889-018-5255-6.

Corona J, Mannucci E, Petrone L, et al. NCEP-ATPIII – defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med. 2007 Jul;4(4 Pt 1):1038-1045. doi: 10.1111/j.1743-6109.2007.00529.x.

Kumar A, Shekhar S, Dhole B. Thyroid and male reproduction. Indian J Endocrinol Metab. 2014;18(1):23-31. doi: 10.4103/2230-8210.126523.

Krassas GE, Papadopoulou F, Tziomalos K, Zeginiadou T, Pontikides N. Hypothyroidism has an adverse effect on human spermatogenesis: A prospective, controlled study. Thyroid. 2008 Dec;18(12):1255-9. doi: 10.1089/thy.2008.0257.

Osuna JA, Gómez-Pérez R, Arata-Bellabarba G, Villaroel V. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl. 2006;52(5):355-61. doi: 10.1080/01485010600692017.

Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009 Dec;5(12):673-81. doi: 10.1038/nrendo.2009.212.

Laaksonen DE, Niskanen L, Punnonen K, et al. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab. 2005 Feb;90(2):712-9. doi: 10.1210/jc.2004-0970.

Simon D, Charles MA, Nahoul K, et al. Association between plasma levels total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab. 1997 Feb;82(2):682-5. doi: 10.1210/jcem.82.2.3766.